Shanghai Haixin Group Co., Ltd. Class ASSE: 600851

Announcement on Subsidiary Obtaining Drug Registration Certificate and Notice of Approval for Marketing Application of API

· Issued by Shanghai Haixin Group Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Subsidiary Obtaining Drug Registration Certificate and Notice of Approval for Marketing Application of API

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment